These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 206138)

  • 41. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE; Deftos LJ; Bartter FC
    J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypercalcemia and elevated serum parathyroid hormone level in association with rhabdomyosarcoma.
    Elomaa I; Lehto VP; Selander RK
    Arch Pathol Lab Med; 1984 Sep; 108(9):701-3. PubMed ID: 6547822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Source of urinary cyclic AMP in response to calcitonin and parathyroid hormone in the rat.
    Firek AF; Ramanathan S; Suh SM
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):147-50. PubMed ID: 2158136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary phosphate and cyclic AMP excretion following citrate-induced hypocalcemic stimulation of the neonatal parathyroid glands.
    Brown DR; Donovan EF; Tsang RC; Bobik CM; Chen IW; Johnson JR
    J Pediatr; 1978 Nov; 93(5):842-6. PubMed ID: 213548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered responses in serum calcium phosphorus and parathyroid hormone to oral calcium load in symptomatic and asymptomatic members of family with idiopathic hypercalcemia.
    Juan D
    Urology; 1984 Aug; 24(2):162-7. PubMed ID: 6087533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnostic tests in parathyroid diseases].
    Burckhardt P
    Schweiz Med Wochenschr; 1986 Feb; 116(6):173-8. PubMed ID: 3006236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypercalcemia in malignant lymphoma. A case in a patient after parathyroidectomy.
    Lokich J; Shevitz F
    JAMA; 1979 Jul; 242(1):66-7. PubMed ID: 582186
    [No Abstract]   [Full Text] [Related]  

  • 48. Parathyroid hormone-related peptide mediates hypercalcemia in an islet cell tumor of the pancreas.
    Mitlak BH; Hutchison JS; Kaufman SD; Nussbaum SR
    Horm Metab Res; 1991 Jul; 23(7):344-6. PubMed ID: 1663481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous parathyroid and pharyngeal tumors with normal PTH and NcAMP.
    Baldwin DB; Rowett DA
    Conn Med; 1980 Sep; 44(9):541-4. PubMed ID: 6250765
    [No Abstract]   [Full Text] [Related]  

  • 50. [Primary hyperparathyroidism. Current aspects of its diagnosis apropos of a case with digestive and neuropsychiatric manifestations].
    Sebert JL; Dupont A; Fournier A; Coevoet B; Lambrey G; Ghighi J; Quichaud J
    Sem Hop; 1978 Dec 18-25; 54(45-46):1488-93. PubMed ID: 219510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma.
    Shionoiri A; Horiuchi T; Onouchi T; Tsutsumi H; Ohta M; Hosoi T; Ito H; Orimo H
    Intern Med; 2000 Oct; 39(10):810-3. PubMed ID: 11030205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Direct inhibitory effect of hypercalcemia on renal actions of parathyroid hormone.
    Beck N; Singh H; Reed SW; Davis BB
    J Clin Invest; 1974 Mar; 53(3):717-25. PubMed ID: 4359938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays.
    Santamaria R; Almaden Y; Felsenfeld A; Martin-Malo A; Gao P; Cantor T; Aljama P; Rodriguez M
    Kidney Int; 2003 Nov; 64(5):1867-73. PubMed ID: 14531822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fulminating hypercalcemia and markedly increased nephrogenous cyclic AMP in a patient with transitional cell carcinoma of the bladder.
    Notman DD; Krauss DJ; Moses AM
    Am J Med; 1979 May; 66(5):870-3. PubMed ID: 220874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypercalcemia of acute renal failure. Clinical significance and pathogenesis.
    de Torrente A; Berl T; Cohn PD; Kawamoto E; Hertz P; Schrier RW
    Am J Med; 1976 Jul; 61(1):119-23. PubMed ID: 937362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of magnesium on the secretion and action of parathyroid hormone.
    Nair KS; Holdaway IM; Evans MC; Cameron AD
    J Endocrinol Invest; 1979; 2(3):267-70. PubMed ID: 231063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrastructure of parathyroid glands and plasma immunoreactive parathyroid hormone in pregnant cows fed normal and high calcium diets.
    Black HE; Capen CC; Arnaud CD
    Lab Invest; 1973 Aug; 29(2):173-85. PubMed ID: 4353416
    [No Abstract]   [Full Text] [Related]  

  • 58. Laboratory aids in the diagnosis of metabolic bone disease.
    Goldsmith RS
    Orthop Clin North Am; 1972 Nov; 3(3):545-60. PubMed ID: 4344932
    [No Abstract]   [Full Text] [Related]  

  • 59. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
    Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
    Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of hypocalcemia on renal phosphorus handling in the rat: interaction with dietary phosphorus and PTH.
    Guntupalli J; Bourke E
    Miner Electrolyte Metab; 1989; 15(4):201-8. PubMed ID: 2548070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.